Tibor Docsa

Synthesis of and a Comparative Study on the Inhibition of Muscle and Liver Glycogen Phosphorylases by Epimeric Pairs of <scp>d</scp>-Gluco- and <scp>d</scp>-Xylopyranosylidene-spiro-(thio)hydantoins and <i>N</i>-(<scp>d</scp>-Glucopyranosyl) Amides

László Somsák, László Kovács, Marietta Tóth et al. · Journal of Medicinal Chemistry · 2001 · 143 citations · Full text

Life Sciences, Biochemistry, Carbohydrate Biochemistry +11

Kinetic and crystallographic studies on 2‐(β‐D‐glucopyranosyl)‐5‐methyl‐1, 3, 4‐oxadiazole, ‐benzothiazole, and ‐benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site

Evangelia D. Chrysina, Magda Kosmopoulou, Constantinos Tiraidis et al. · Protein Science · 2005 · 86 citations · Full text

Pharmacy, Biochemistry, Pharmacology +16

Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition

David Goyard, Bálint Kónya, Aikaterini S. Chajistamatiou et al. · European Journal of Medicinal Chemistry · 2015 · 83 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Synthesis of 1-(d-glucopyranosyl)-1,2,3-triazoles and their evaluation as glycogen phosphorylase inhibitors

Éva Bokor, Tibor Docsa, Pál Gergely et al. · Bioorganic & Medicinal Chemistry · 2009 · 82 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +7

Efficient inhibition of muscle and liver glycogen phosphorylases by a new glucopyranosylidene-spiro-thiohydantoin

Erzsébet Ősz, László Somsák, László Szilágyi et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 77 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14